A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Conditions
Severe Asthma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site 13, Bakersfield, California, United States
Research Site 12, Inglewood, California, United States
Research Site 10, West Covina, California, United States
Research Site 06, Miami, Florida, United States
Research Site 03, Miami, Florida, United States
Research 09, Orlando, Florida, United States
Research Site 01, Tamarac, Florida, United States
Research Site 04, Tampa, Florida, United States
Research Site 05, Tampa, Florida, United States
Research Site 20, Fall River, Massachusetts, United States
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 02, Ypsilanti, Michigan, United States
Research Site 11, Dayton, Ohio, United States
Research Site 21, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 16, Rock Hill, South Carolina, United States
Research Site 17, San Antonio, Texas, United States
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 07, Sugar Land, Texas, United States
Research Site 08, Williamsburg, Virginia, United States
Research Site 31, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 33, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 22, Mechelen, Vlaams Brabant, Belgium
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 23, Matsuyama, Ehime, Japan
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 32, Fukui-shi, Fukui, Japan
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 37, Isesaki-Shi, Gunma, Japan
Contact: Study coordinator (solairiastudy@generatebiomedicines.com Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 34, Niigata, Niigata, Japan
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 14, Shinagawa-Ku, Tokyo, Japan
Research Site 15, Fukuoka, Tukuoka, Japan
Research Site 38, Ube, Yamaguchi, Japan
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 19, Belgrade, Belgrade, Serbia
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 18, High Wycombe, Buckinghamshire, United Kingdom
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 28, Bristol, England, United Kingdom
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 30, London, England, United Kingdom
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 25, Thetford, England, United Kingdom
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 26, London, Greater London, United Kingdom
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033Research Site 27, Nottingham, Nottinghamshire, United Kingdom
Contact: Study coordinator (Generate Recruitment) · solairiastudy@generatebiomedicines.com · 888-469-0033
Study leads
Snodgres
Study Director
Generate Biomedicines